Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Crohn Disease × Adalimumab × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1 Sarcoidosis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1

Interventions

MEDI2070 2 secukinumab 1 Vitamin E 1 Vaccines 1 Ustekinumab 1 Saline Solution 1 Medical Marijuana 1 Iron-Dextran Complex 1 Herpes Zoster Vaccine 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04655807 2025-04-27

DUET

Janssen Research & Development, LLC

Phase 2 Withdrawn

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡